PC-002 (Sepantronium Bromide) Enhances the Antitumor Efficacy of Anti-CD20 Antibody By CD20 Upregulation

被引:0
|
作者
Jiang, Vernon [1 ]
Li, Xiang [1 ]
He, Na [1 ]
Lv, Yan [1 ]
Wang, Haiyue [1 ]
Zhang, Ming [1 ]
Zhai, Heiyan [1 ]
Yang, Zhen [1 ]
Yang, Yi [1 ]
Guo, Dagang [1 ]
Cao, Zhixiang [1 ]
Chen, Yiyou [1 ]
机构
[1] Cothera Biosci, San Mateo, CA USA
关键词
D O I
10.1182/blood-2024-209648
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5822 / 5823
页数:2
相关论文
共 50 条
  • [41] INFLUENCE OF THE B-CELL RECEPTOR (BCR) SIGNALING PATHWAYS ON CD20 LEVELS IN TUMOR CELLS AND ANTITUMOR ACTIVITY OF ANTI-CD20 MONOCLONAL ANTIBODIES
    Winiarska, M.
    Bojarczuk, K.
    Wanczyk, M.
    Dwojak, M.
    Zapala, P.
    Miazek, N.
    Siernicka, M.
    Golab, J.
    HAEMATOLOGICA, 2013, 98 : 126 - 127
  • [42] What signals are generated by anti-CD20 antibody therapy?
    Bonavida B.
    Current Hematologic Malignancy Reports, 2006, 1 (4) : 205 - 213
  • [43] Anti-CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis
    Korhonen, Riku
    Moilanen, Eeva
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106 (01) : 13 - 21
  • [45] Evolution of anti-CD20 monoclonal antibody therapeutics in oncology
    Oflazoglu, Ezogelin
    Audoly, Laurent P.
    MABS, 2010, 2 (01) : 14 - 19
  • [46] Anti-CD20 monoclonal antibody therapy in multiple myeloma
    Kapoor, Prashant
    Greipp, Patricia T.
    Morice, William G.
    Rajkumar, S. Vincent
    Witzig, Thomas E.
    Greipp, Philip R.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (02) : 135 - 148
  • [47] Anti-CD20 Antibody Therapy and Susceptibility to Pneumocystis Pneumonia
    Elsegeiny, Waleed
    Eddens, Taylor
    Chen, Kong
    Kolls, Jay K.
    INFECTION AND IMMUNITY, 2015, 83 (05) : 2043 - 2052
  • [48] Which Anti-CD20 Antibody Is Better in Follicular Lymphoma?
    Armitage, James O.
    Longo, Dan L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (14) : 1389 - 1390
  • [49] Anti-CD20 for rheumatoid arthritis
    Edwards, JC
    Leandro, MJ
    Cambridge, G
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 25 - 25
  • [50] Immunotherapy with anti-CD20 compounds
    von Schilling, C
    SEMINARS IN CANCER BIOLOGY, 2003, 13 (03) : 211 - 222